Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 TERT promoter mutations in thyroid cancer: growing evidence for a predictor of poor outcome.

Literature DB >> 31328111

TERT promoter mutations in thyroid cancer: growing evidence for a predictor of poor outcome.

Jianliang Man¹, Norman Nicolson¹, Courtney Gibson¹, Tobias Carling¹.

Abstract

Entities: Disease Gene

Year: 2019 PMID： 31328111 PMCID： PMC6606470 DOI： 10.21037/gs.2019.04.11

Source DB: PubMed Journal: Gland Surg ISSN： 2227-684X

Keyword Cloud
References

× No keyword cloud information.

10 in total

1. Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.

Authors: Carla Colombo; Marina Muzza; Maria Carla Proverbio; Delfina Tosi; Davide Soranna; Chiara Pesenti; Stefania Rossi; Valentina Cirello; Simone De Leo; Nicola Fusco; Monica Miozzo; Gaetano Bulfamante; Leonardo Vicentini; Stefano Ferrero; Antonella Zambon; Silvia Tabano; Laura Fugazzola
Journal: Thyroid Date: 2019-01-16 Impact factor: 6.568

Review 2. TERT Promoter Mutations in Thyroid Cancer.

Authors: Ali S Alzahrani; Rawan Alsaadi; Avaniyapuram Kannan Murugan; Bakr Bin Sadiq
Journal: Horm Cancer Date: 2016-02-22 Impact factor: 3.869

Review 3. The role of telomeres in stem cells and cancer.

Authors: Cagatay Günes; K Lenhard Rudolph
Journal: Cell Date: 2013-01-31 Impact factor: 41.582

4. TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.

Authors: Xue Yang; Jiao Li; Xiaoyi Li; Zhiyong Liang; Wen Gao; Jun Liang; Shujun Cheng; Yansong Lin
Journal: J Nucl Med Date: 2016-08-04 Impact factor: 10.057

5. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors: Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal: J Clin Invest Date: 2016-02-15 Impact factor: 14.808

6. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.

Authors: Claire Bournaud; Françoise Descotes; Myriam Decaussin-Petrucci; Julien Berthiller; Christelle de la Fouchardière; Anne-Laure Giraudet; Mireille Bertholon-Gregoire; Philip Robinson; Jean-Christophe Lifante; Jonathan Lopez; Françoise Borson-Chazot
Journal: Eur J Cancer Date: 2019-01-12 Impact factor: 9.162

TERT promoter mutations in thyroid cancer: growing evidence for a predictor of poor outcome.

1. Impact of Mutation Density and Heterogeneity on Papillary Thyroid Cancer Clinical Features and Remission Probability.

Review 2. TERT Promoter Mutations in Thyroid Cancer.

Review 3. The role of telomeres in stem cells and cancer.

4. TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.

5. Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

6. TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma.

Review 7. Telomerase and the search for the end of cancer.

Review 8. TERT promoter mutations in thyroid cancer.

9. Highly prevalent TERT promoter mutations in aggressive thyroid cancers.

10. Specific association of human telomerase activity with immortal cells and cancer.